Our results strongly suggest that PDI, PDIA6, PDIR, ERp57, ERp72 and AGR3 expression can be useful biomarkers for clear cell ovarian carcinoma but additional studies are required to further validate the prognostic role of PDIs in these cancers. This evidence concerns the gene PDIA3 and ovarian clear cell cancer.